Page last updated: 2024-08-24

octyl glucoside and B-Cell Lymphoma

octyl glucoside has been researched along with B-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borisch, B; Hoessli, DC; Klages, N; Kulangara, K; Palomba, C; Semac, I; van Echten-Deckert, G	1

Other Studies

1 other study(ies) available for octyl glucoside and B-Cell Lymphoma

Article	Year
Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells. Cancer research, 2003, Jan-15, Volume: 63, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; beta-Cyclodextrins; CD55 Antigens; Cyclodextrins; Glucosides; Humans; Lymphoma, B-Cell; Membrane Lipids; Membrane Microdomains; Membrane Proteins; Phospholipase D; Phosphoproteins; Rituximab; src-Family Kinases; Type C Phospholipases	2003

Article

Year

Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells.

Cancer research, 2003, Jan-15, Volume: 63, Issue:2

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; beta-Cyclodextrins; CD55 Antigens; Cyclodextrins; Glucosides; Humans; Lymphoma, B-Cell; Membrane Lipids; Membrane Microdomains; Membrane Proteins; Phospholipase D; Phosphoproteins; Rituximab; src-Family Kinases; Type C Phospholipases

2003